top of page
Browse by category
Search
Metabolites produced in intestine play central role in controlling obesity and diabetes
A study conducted at Harvard University has identified a group of metabolites that travel from the intestine to the liver and then to the heart, where they are pumped throughout the body. These metabolites play an important role in controlling metabolic pathways in the liver and insulin sensitivity. This discovery may contribute to future treatments for obesity and type 2 diabetes. Diagram summarising the experiments, which analyzed metabolites present in the peripheral blood
The pathophysiological relationship obstructive sleep apnoea syndrome, obesity and metabolic syndrome
Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnoea...
Metabolic syndrome factors associated with increased bowel cancer risk
Metabolic disorders such as obesity, high blood pressure and non-alcoholic fatty liver diseases have been directly linked to an increased...
SASI bypass and OAGB more effective than SG in the treatment of metabolic syndrome
A retrospective analysis of sleeve gastrectomy (SG), one-anastomotic gastric bypass (OAGB) and single anastomosis sleeve ileal (SASI)...
LIGHT-UP: GS200 may improve insulin sensitivity and positively impact metabolic syndrome
Outcomes from the LIGHT-UP study that evaluated the safety and efficacy of GS200, an investigational oral hydrogel, has concluded the...
Healthcare shift work associated with increased odds of metabolic syndrome
The first meta-analysis to explore the association between shift employment and the possibility of developing metabolic syndrome (MetS),...
Neutralising asprosin breaks disease cycle promoting metabolic syndrome and obesity
Researchers at Harrington Discovery Institute at University Hospitals (UH) and Case Western Reserve University have discovered a...
Browse by tag
bottom of page